Takeda shares drop after report on $6 billion jury award over Actos

TOKYO Mon Apr 7, 2014 11:34pm EDT

The logo of Japanese Takeda Pharmaceutical Co is seen at an office building in Glattbrugg near Zurich March 7, 2012. REUTERS/Arnd Wiegmann

The logo of Japanese Takeda Pharmaceutical Co is seen at an office building in Glattbrugg near Zurich March 7, 2012.

Credit: Reuters/Arnd Wiegmann

Related Topics

TOKYO (Reuters) - Shares in Takeda Pharmaceutical Co Ltd (4502.T) were down nearly 6 percent on Tuesday morning after Bloomberg news reported that a U.S. jury ordered it to pay $6 billion in punitive damages in a case claiming it hid cancer risks of its Actos diabetes drug.

Takeda representatives could not immediately be reached for comment.

Takeda's shares were down 5.7 percent at midday at 4,545 yen, after falling as far as 4,483, a six-month low.

(Reporting by Ritsuko Shimizu and Edmund Klamann; Editing by Dominic Lau)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.